In Vitro Diagnostics Business Outlook, 2024 (6 updates)

ISSUE 2 of 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry

In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
A comprehensive view of the IVD market with test categories covered and company briefs
M&A activities, selected partnerships & collaborations, partnership deals, and more
Industry & region watch to help tailor strategies
Analysis of news and events and reporting on news not easily available

Market Analysis: Clinical Chemistry

Overview of Clinical Chemistry Market
Market Outlook
Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ Millions)
Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
Major Product Activity
Lab-based Clinical Chemistry
Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ Millions)
Point-Of-Care Clinical Chemistry
Table: Market Summary: Poc-based Clinical Chemistry Market, 2023 and 2028 ($ Millions)
Regional Market
Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ Millions)
Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)
Top Company Briefs
Roche
Abbott
Danaher

Executive News Briefing

Financial Highlights: Biomérieux & Sekisui Diagnostics

Figure: Biomérieux Sales Distribution, by Business Segment, 2023 (%)
Table: Biomérieux Financial Review, by Business Segment, Fy 2022 - Fy 2-23 (€M)
Figure: Biomérieux Fy 2022 vs Fy 2023 Regional Sales Breakdown (€M)
Table: Sekisui Chemical Financial Results, Fy 2022 and Fy 2023 (Billions of Yen)
Table: Sekisui Chemical Annual Overview and Focus, Fy 2023 and Fy 2024 (Billions of Yen)
Table: Sekisui Chemical Net Sales, by Segment, Fy22 and Fy23 (Billions of Yen)
Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 Fy22 - Q4Fy23 (Millions of Yen)

Diagnostic Market Mergers, Acquisitions and Partnership Deals

Industry Watch

Region Watch

Japan
Figure: Japan National Health Expenditures, Year-On-Year Growth Rate, 1985-2019 (Yen Trillion, %)
Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds Per Hospital, 2015-2019
Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
Figure: Japan Ivd Market, by Segment, 2023 (%)

Broad-based Company Announcements

PURCHASE OPTIONS

1 - 5 User License PDF - 1 Year Subscription

Enterprise License PDF - 1 Year Subscription

License	Format	Properties	Price
1 - 5 USER LICENSE PDF - 1 Year Subscription	The product is a PDF. The subscription period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4883EUR$4,995USD£4,079GBP
ENTERPRISE LICENSE PDF - 1 Year Subscription	The product is a PDF. The subscription period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€9771EUR$9,995USD£8,162GBP